"ADA 2018 - Trends In Insulin Pen Priming" - Kelly L. Close
At the American Diabetes Association 78th Scientific Sessions this year, first author, Grenye O’Malley, MD, chief endocrine fellow in the division of endocrinology and bone disease at the Icahn School of Medicine at Mount Sinai, and final author Carol Levy, MD, CDE, director of the Mount Sinai Diabetes Center at the Icahn School of Medicine at Mount Sinai will be presenting a late-breaker modestly titled “Trends in Insulin Pen Priming,” which seems likely to include data from the three-month NIH-funded study of TypeZero’s inControl MDI Advisor, which is using NFC-enabled NovoPen Echos and connected Tresiba pens supplied by Novo Nordisk.
- Carol Levy, MD, CDE, Associate Professor, Endocrinology, Diabetes and Bone Disease, Obstetrics, Gynecology and Reproductive Science, Director, Mount Sinai Diabetes Center, T1 Diabetes Clinical Research, Icahn School of Medicine at Mount Sinai
- Grenye O’Malley, MD, Chief Endocrine Fellow, Division of Endocrinology and Bone Disease, Icahn School of Medicine at Mount Sinai
Learn more: No web link available.